01.01.2015 Views

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ABSTRACTS – Contributed Posters<br />

Avenue, Los Angeles, CA 90095; cahlos.an22@gmail.com,<br />

katelynn.barkley@gmail.com).<br />

Cisplatin (Cis) and Paclitaxel (Pac) are chemotherapy<br />

drugs used to stop cancer cell proliferation and N-Acetyl-<br />

Cysteine (NAC) is a supplemental drug used to supply<br />

nutrients to the body. Objective: To observe the synergistic<br />

effects of Cis and Pac combined with NAC, to treat pancreatic<br />

cancer stem cells (BXPC3s). Methods: BXPC3s were treated<br />

with four different concentrations (10, 20, 30, and 40 µg)<br />

of Cis, Pac, Cis+NAC (20µg), Pac+NAC (20µg). Cell death<br />

assay using flow cytometry were employed to examine the<br />

BXPC3s after a 24 hour treatment. Propidium Iodide (PI)<br />

was used because it can integrate within the cells that have<br />

a porous membrane, an indication of cell death, and allow<br />

quantification of dead tumor cells. Results: More PI was<br />

found in Cis treated BXPC3 than Pac treated BXPC3. The<br />

amount of PI decreased by 20% in Cis+NAC treated BXPC3<br />

when compared to Cis-only treated BXPC3 and increased by<br />

40% in Pac+NAC treated BXPC3 when compared to Paconly<br />

treated BXPC3. Conclusion: Cis is more effective at<br />

treating BXPC3s than Pac; however, the addition of NAC<br />

inhibited the killing effects of Cis while synergistically<br />

increasing the killing effects of Pac on BXPC3s. Discussion:<br />

Since Cis and Pac have negative side effects when used to<br />

treat patients, the addition of a supplement drug NAC might<br />

help to control such negative side effects without lowering<br />

the efficiency of the chemotherapy drugs. However, further<br />

research in vivo is needed.<br />

169 Do Human Multiple Myeloma Cells Express IL-6<br />

Family Inflammatory Cytokines DANIELLE HEDEEN*,<br />

DOLLIE LaJOIE, and CHERYL JORCYK (Department<br />

of Biological Sciences, Boise State University, 1910<br />

University Drive, Boise, ID 83725; daniellehedeen@u.<br />

boisestate.<strong>edu</strong>).<br />

Multiple myeloma (MM) is a cancer of the plasma cells,<br />

found in the bone marrow, which leads to the formation<br />

of multiple tumors in bone. Plasma cells arise from B<br />

lymphocytes, and produce immunoglobulins that help rid the<br />

body of infection. It is known that the inflammatory cytokine,<br />

Interleukin (IL)-6, is an important growth factor for human<br />

MM, and human MM cells are known to express IL-6. We<br />

hypothesize that other cytokines in the IL-6 family may also<br />

be expressed in human MM. For the model system, we are<br />

using three human MM cell lines (RPMI-8226, MM1.S,<br />

and MM1.R) grown in RPMI-1640 media with 10% FBS<br />

and penicillin-streptomycin. The secretion of IL-6-family<br />

cytokines by these three cell lines will be investigated by<br />

enzyme-linked immunosorbent assay (ELISA), reverse<br />

transcriptase polymerase chain reaction (RT-PCR), and<br />

Western blot analysis. Family member receptor expression<br />

will also be investigated by RT-PCR. Furthermore, we will<br />

investigate the effect of IL-6 family cytokines on proliferation<br />

in these MM cell lines, and vascular endothelial growth<br />

factor (VEGF) secretion by ELISA. Investigating the effects<br />

of IL-6 family inflammatory cytokines and their signaling<br />

in these cell lines will lead to a better understanding of MM<br />

biology and potentially identify novel therapeutic targets.<br />

170 Overexpression of SOX4 Leads to Down Regulation<br />

of UBC9, JOHANNA LEWIS* 1 , RUBY ENRIQUEZ* 1 ,<br />

MIN ZHANG 2 , and SHEN HU 2 ( 1 Howard Hughes Medical<br />

Institute Pre-College Science Education Program; 2 UCLA<br />

School of Dentistry, Division of Oral Biology and Medicine,<br />

10833 Le Conte Avenue, Room 63-070 CHS, Los Angeles,<br />

CA 90095; jjlewis46@gmail.com, rubyenriquez@live.com).<br />

Sex Determining Region-Y4 (SOX4) is a transcription<br />

factor, which plays an important role in embryonic<br />

development. It is composed of three regions, High Mobility<br />

Group box (HMG), Glycine Rich Region (GRR) and<br />

Serine Rich Region (SSR). SOX4 expression was found<br />

to be deregulated in many types of cancer. However, the<br />

underlying mechanism is still not clear. Objective: To study<br />

the effects of the overexpression of SOX4 in oral cancer.<br />

Methods: Sox4-FLAG plasmid was transformed into E.<br />

coli cells. Plasmid DNA was purified by Maxi plasmid<br />

DNA purification kit (Qiagen). The concentration of DNA<br />

is determined by nanodrop spectrometer and the size of<br />

plasmid is confirmed by agarose gel electrophoresis. The<br />

oral cancer cell line UM1 was used to overexpress SOX4.<br />

The overexpression of SOX4 is confirmed by Western blot<br />

analysis with anti-FLAG mouse monoclonal antibody and<br />

anti SOX4 mouse monoclonal antibody, respectively. The<br />

expression of Ubiquitin Conjugating Enzyme-9(UBC9),<br />

which plays an important role in metastasis, was detected<br />

with anti UBC9 rabbit polyclonal antibody. Results: SOX4<br />

is overexpressed in UM1 cells by introduction of SOX4-<br />

FLAG plasmid into the cells; the overexpression of SOX4<br />

in cell line UM1 resulted in the down regulation of UBC9.<br />

Discussion: Further research on SOX4 for a more precise<br />

outcome of its effects may result in a possible cure for oral<br />

cancer. Conclusion: Overexpression of SOX4 might limit<br />

metastasis via down-regulation of the expression of target<br />

proteins, such as UBC9, which have a role in metastasis.<br />

171 TCDD Treatment Suppresses Vitamin A Storage and<br />

Activates LX-2 Human Hepatic Stellate Cells, WENDY A<br />

HARVEY*, JALISA J ROBINSON, REILLY J CLARK,<br />

CALEB D HUANG, and KRISTEN A MITCHELL<br />

(Department of Biology, Boise State University, 1910<br />

University Drive, Boise ID 83725; wendyharvey@u.<br />

boisestate.<strong>edu</strong>).<br />

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an<br />

environmental pollutant in the family of halogenated<br />

aromatic hydrocarbons. Exposure of rodents to TCDD has<br />

been shown to modulate retinol metabolism by decreasing<br />

hepatic retinyl esters, yet the mechanism by which this occurs<br />

has not been identified. In the present study, we used the<br />

97

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!